Berntsen Natalie L, Klingenberg Olav, Juran Brian D, Benito de Valle Maria, Lindkvist Björn, Lazaridis Konstantinos N, Boberg Kirsten Muri, Karlsen Tom H, Hov Johannes Roksund
Norwegian Primary Sclerosing Cholangitis Research Center, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Research Institute of Internal Medicine, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway; KG Jebsen Inflammation Research Centre, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway; Department of Medical Biochemistry, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Gastroenterology. 2015 May;148(5):924-927.e2. doi: 10.1053/j.gastro.2015.01.041. Epub 2015 Feb 2.
Increased serum levels of IgG4 have been reported in 9%-15% of patients with primary sclerosing cholangitis (PSC); it is not clear whether this increase contributes to pathogenesis. We performed genetic analyses of the HLA complex in patients with PSC from Norway, Sweden, and from the United States. We found an association between levels of IgG4 above the upper reference limit and specific HLA haplotypes. These patients had a significantly lower frequency of the strongest PSC risk factor, HLA-B08, than patients without increased IgG4, and significantly higher frequencies of HLA-B07 and HLA-DRB1*15. HLA genotype therefore might affect the serum concentration of IgG4, and increased IgG4 might be a marker of a distinct phenotype of PSC.
据报道,9% - 15%的原发性硬化性胆管炎(PSC)患者血清IgG4水平升高;目前尚不清楚这种升高是否与发病机制有关。我们对来自挪威、瑞典和美国的PSC患者进行了HLA复合体的基因分析。我们发现IgG4水平高于参考上限与特定的HLA单倍型之间存在关联。与IgG4未升高的患者相比,这些患者中最强的PSC风险因素HLA - B08的频率显著更低,而HLA - B07和HLA - DRB1*15的频率显著更高。因此,HLA基因型可能会影响IgG4的血清浓度,而IgG4升高可能是PSC一种独特表型的标志物。